SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
KAI Pharmaceuticals, Inc. Announces Late Breaker Poster Presentation of KAI-4169 Phase 2 Clinical Results at the American Society of Nephrology’s Kidney Week 2011